Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
AIChE Annual MeetingAIChE Annual Meeting
Not Confirmed
Not Confirmed
02-06 November, 2025
Not Confirmed
Not Confirmed
03-06 November, 2025
Not Confirmed
Not Confirmed
03-05 November, 2025
List your booth number for exhibitions, ask us 
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
AIChE Annual MeetingAIChE Annual Meeting
Industry Trade Show
Not Confirmed
02-06 November, 2025
Industry Trade Show
Not Confirmed
03-06 November, 2025
Industry Trade Show
Not Confirmed
03-05 November, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company] 
					DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

09 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251009963422/en/Vividion-Announces-Publication-in-Science-of-Preclinical-Data-on-Covalent-Inhibitors-of-RAS-PI3K-that-Block-Tumor-Growth

13 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250813751175/en/Vividion-Therapeutics-Appoints-Sam-Whiting-M.D.-Ph.D.-as-Chief-Medical-Officer

04 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250604147547/en/Vividion-Therapeutics-and-Bayer-Further-Strengthen-Oncology-Development-Pipeline-with-Clinical-Stage-WRN-Inhibitor

04 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/bayers-vividion-secures-rights-worlds-only-clinical-stage-wrn-inhibitor-partner-roche

03 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250403585991/en/Vividion-Therapeutics-Doses-First-Patient-in-Phase-I-Study-of-RAS-PI3K-Inhibitor-for-Treatment-of-Advanced-Solid-Tumors

13 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/navega-therapeutics-appoints-new-strategic-advisors-to-the-board-of-advisors-302375529.html
ABOUT THIS PAGE
